Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd.
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Alkem Laboratories Ltd.
Case Number: 1:2020cv01286
Filed: September 24, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Leonard P Stark
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on October 1, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
October 1, 2020 Filing 7 WAIVER OF SERVICE returned executed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S: For Alkem Laboratories Ltd. waiver sent on 9/30/2020, answer due 12/29/2020. (Balick, Steven)
September 30, 2020 Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:20-cv-01286-LPS, 1:20-cv-01287-LPS, 1:20-cv-01295-LPS, 1:20-cv-01296-LPS, 1:20-cv-01297-LPS (rjb)
September 25, 2020 No Summons Issued. (sam)
September 24, 2020 Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (sam)
September 24, 2020 Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (sam)
September 24, 2020 Filing 4 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 11, 2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 1/10/2023. (sam)
September 24, 2020 Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (sam)
September 24, 2020 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
September 24, 2020 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Alkem Laboratories Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3222894.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(sam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Alkem Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Otsuka Pharmaceutical Co., Ltd.
Represented By: Steven J. Balick
Represented By: Andrew Colin Mayo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: H. Lundbeck A/S
Represented By: Steven J. Balick
Represented By: Andrew Colin Mayo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?